In a notable development for medical technology, the Dublin-based medtech company Vertigenius successfully closed a funding round of €2.55 million. The round was led by Atlantic Bridge and included support from several investors, such as Enterprise Ireland, MedTech Syndicate, IRRUS Investments, and Xcendra Ventures. Founded by Dr. Dara Meldrum at Trinity College Dublin, the company has developed a wearable sensor and app aimed at monitoring the treatment of vertigo in a home setting. This device allows healthcare practitioners to remotely track patients’ progress and adjust their treatment plans accordingly. Having achieved FDA registration, the company introduced its device into the US market in October 2025. Vertigenius has seen early success, deploying the technology in 20 clinics across 11 states, with approximately 3,000 patients being treated so far. This promising adoption indicates a strong clinical value of the platform, signaling substantial commercial opportunities in a market projected to be worth $3 billion and encompassing over 5,000 vestibular clinics. The fresh capital acquired through this funding round will be utilized to enhance the company's presence in the United States by expanding its US commercial team. Vertigenius has already added two sales directors in the country to facilitate this growth. Moreover, the funding will also be allocated to hiring in clinical research, product research and development, quality assurance, and regulatory affairs at their headquarters in Ireland. This expansion strategy highlights Vertigenius’s commitment to transforming the treatment of vertigo on a larger scale. Looking ahead, Vertigenius plans to broaden its reach over the next five years, aiming to penetrate further into the European market and explore opportunities in Asia Pacific. Mark Barry, CEO of Vertigenius, emphasized the transformative potential of their device, stating it converts real-time data into clinically relevant insights that consequently allow providers to customize treatments better. The unique platform designed by Vertigenius addresses critical gaps in vestibular care and significantly improves the patient care experience, thereby contributing to enhanced standards within the healthcare community.